Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Cimetidine · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| Omeprazole sodium bicarbonate immediate release PWD/FS | EXPERIMENTAL | - |
| Cimetidine IV | ACTIVE_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| Omeprazole sodium bicarbonate immediate release PWD/FS | DRUG | - |
| Cimetidine IV | DRUG | - |
Patients will be included in the trial if they meet all of the following criteria: 1. An adult or adolescent (greater than or equal to 16 years of age) male or non-pregnant female requiring mechanical ventilation for greater than or equal to 48 hours. 2. An anticipated ICU stay of greater than or e...
Cimetidine is a small molecule being studied for the treatment of Upper Gastrointestinal Bleeding. It is currently in Phase 3 clinical development. The drug is being evaluated for its safety and efficacy in managing this condition, which involves bleeding in the upper part of the digestive tract.
Cimetidine is being developed by Bausch Health Companies Inc., a company traded on the stock exchange under the ticker BHC. The company is conducting clinical research to evaluate the drug's potential in treating Upper Gastrointestinal Bleeding.
Cimetidine is currently in Phase 3 clinical development. It is an investigational drug, meaning it has not yet been approved for commercial use. The Phase 3 trial is designed to assess the drug's safety and efficacy in patients with Upper Gastrointestinal Bleeding.
Cimetidine is being studied in a Phase 3 clinical trial with the identifier NCT00045799. This completed trial, titled 'Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill,' enrolled 354 participants in the United States. The study was randomized, double-blind, and active-controlled.
Cimetidine is not the same as Omeprazole Sodium Bicarbonate. The clinical trial NCT00045799, which studies Cimetidine, compares it against an active control, Omeprazole Sodium Bicarbonate. Cimetidine is a separate drug being evaluated for its effects on Upper Gastrointestinal Bleeding.